Internationally recognized expert and educator in genitourinary pathology having co-authored the current World Health Organization (WHO) classification systems for urothelial tumors and renal neoplasms; currently involved in developing the 2015 WHO classification systems for tumors of the prostate, bladder, kidney and testis.
• Chairman and Professor, and Medical Director of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center (2006-current). Transformed a community-based practice with academic interest into a nationally and internationally recognized academic department. Developed Translational Pathology and Experimental Pathology Sections and Institutional Biorepository and Morphology Core at the Medical Center.
• Professor of Pathology & Vice Chair of Department of Pathology and Laboratory Medicine at UCLA, David Geffen School of Medicine (2007-current).
• Editor-in-Chief of the 8th edition of the American Joint Committee on Cancer (AJCC) staging manual coordinating the activities of over 500 national and international authorities in cancer to outline the next edition of cancer staging (staging manual to be published in 2016. The AJCC staging system is widely used in clinical decision-making of all patients with cancer, to define clinical and translational research and healthcare policy in cancer.
• Chairman and Professor, and Medical Director of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center (2006-current). Transformed a community-based practice with academic interest into a nationally and internationally recognized academic department. Developed Translational Pathology and Experimental Pathology Sections and Institutional Biorepository and Morphology Core at the Medical Center.
• Professor of Pathology & Vice Chair of Department of Pathology and Laboratory Medicine at UCLA, David Geffen School of Medicine (2007-current).
• Editor-in-Chief of the 8th edition of the American Joint Committee on Cancer (AJCC) staging manual coordinating the activities of over 500 national and international authorities in cancer to outline the next edition of cancer staging (staging manual to be published in 2016. The AJCC staging system is widely used in clinical decision-making of all patients with cancer, to define clinical and translational research and healthcare policy in cancer.